Clinical trials as treatment option: Bioethics and health care disparities in substance dependency
Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of partic...
Saved in:
Published in | Social science & medicine (1982) Vol. 69; no. 12; pp. 1784 - 1790 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
01.12.2009
Elsevier Pergamon Press Inc |
Series | Social Science & Medicine |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities – quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians – the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process. |
---|---|
AbstractList | Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process. [PUBLICATION ABSTRACT] Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process. [Copyright Elsevier Ltd.] Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process.Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process. Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process. Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process. All rights reserved, Elsevier |
Author | Timmermans, Stefan McKay, Tara |
Author_xml | – sequence: 1 givenname: Stefan surname: Timmermans fullname: Timmermans, Stefan email: stefan@soc.ucla.edu – sequence: 2 givenname: Tara surname: McKay fullname: McKay, Tara |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22225524$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19819059$$D View this record in MEDLINE/PubMed http://econpapers.repec.org/article/eeesocmed/v_3a69_3ay_3a2009_3ai_3a12_3ap_3a1784-1790.htm$$DView record in RePEc |
BookMark | eNqNktuKFDEQhhtZcQ_6CtoI6tWMOXSSjuDFOniCFW_0OqSTaiZDT7pNMgvz9lY7syvshWNIKoF89VdI_ZfVWRwjVNULSpaUUPl2s8yjyy5swS8ZIXo5T6ofVRe0VXwheKPOqgvClFpoweV5dZnzhhBCScufVOdUt1QToS-qbjWEGJwd6pKCHXJtM57Ali3EUo9TCWN8V38II5R1cHgdfb0GO5R17WyC2oc82RRKgFyHWOddl4uNDi9ggughuv3T6nGPyvDsuF9VPz99_LH6srj5_vnr6vpm4YQmZcGIEs5b0bGGqdYr73smiOo7Kygwie-VDXSEecel7p1mpOk67ZinGDsp-VX15qA7pfHXDnIx25AdDIONMO6yUbyhkqEmkq__SUrKBW01Pw0SziWn6iTIFROM6RbBlw_AzbhLEf_FME6aVhOuEfp2gBJ-ojNTClub9gYAsOvYcnNruJUawx7X3H_cAi7KMEzzQbWNoUoTsy5b1Ht-LLrr5vQ7wTsbIPDqCNiMXugTtjDke47hEII1yKkD59KYc4L-rxQxszHNxtwb0_x52DzpXOH9g0wXip3dVZINw3_kXx_yAR10GyAZhNBd4EMCV4wfw0mN3ysGAqw |
CODEN | SSMDEP |
CitedBy_id | crossref_primary_10_3917_rac_017_0185 crossref_primary_10_1016_j_socscimed_2009_09_015 crossref_primary_10_9758_cpn_2016_14_1_17 crossref_primary_10_1093_phe_phw004 crossref_primary_10_1007_s12687_014_0186_0 crossref_primary_10_1111_maq_12647 crossref_primary_10_1177_10497323211016408 crossref_primary_10_1177_1740774515589592 crossref_primary_10_1016_j_socscimed_2009_09_014 crossref_primary_10_3917_sss_361_0005 crossref_primary_10_1080_17530350_2011_535332 crossref_primary_10_1016_j_socscimed_2016_08_019 crossref_primary_10_1097_QAI_0000000000001814 crossref_primary_10_3390_ijerph18052611 crossref_primary_10_3917_autr_063_0145 crossref_primary_10_1371_journal_pmed_1003705 crossref_primary_10_1016_j_socscimed_2022_115132 crossref_primary_10_1186_1475_2875_13_217 crossref_primary_10_1016_j_socscimed_2013_12_011 crossref_primary_10_3917_rfs_613_0405 crossref_primary_10_1051_medsci_2012281s109 crossref_primary_10_1186_1472_6939_15_68 crossref_primary_10_1097_PSY_0b013e318218e1fb crossref_primary_10_1111_1467_9566_13297 crossref_primary_10_1177_0306312712472406 crossref_primary_10_1200_OP_21_00328 crossref_primary_10_1016_j_socscimed_2010_02_012 crossref_primary_10_4000_anthropologiesante_6272 crossref_primary_10_1111_j_1548_1387_2012_01222_x crossref_primary_10_1016_j_socscimed_2011_11_012 crossref_primary_10_1590_1981_7746_sol00139 crossref_primary_10_1590_1983_80422020284430 crossref_primary_10_1177_0022146516684537 crossref_primary_10_1016_j_hlpt_2015_10_002 crossref_primary_10_1525_sod_2019_5_1_9 crossref_primary_10_1016_j_socscimed_2014_08_023 crossref_primary_10_1057_biosoc_2014_14 crossref_primary_10_1177_16094069221131168 crossref_primary_10_1016_j_drugalcdep_2011_11_005 crossref_primary_10_1016_j_socscimed_2012_04_022 crossref_primary_10_1177_0162243910366155 crossref_primary_10_1186_gm525 crossref_primary_10_1111_1467_9566_12094 crossref_primary_10_1111_1467_9566_13381 crossref_primary_10_1016_j_socscimed_2015_01_038 crossref_primary_10_1057_biosoc_2016_11 crossref_primary_10_1080_23294515_2017_1305007 |
Cites_doi | 10.1353/pbm.2005.0092 10.1111/j.1748-720X.2000.tb00685.x 10.1097/01.CCM.0000054907.33928.48 10.1056/NEJMsb030228 10.1086/341855 10.1017/S1745855207005042 10.1016/0160-2527(82)90026-7 10.1111/j.1360-0443.2007.01773.x 10.1016/S0140-6736(01)06805-2 10.1371/journal.pmed.0040324 10.1353/hcr.2007.0092 10.1162/152651602317533523 10.1016/S0140-6736(03)15383-4 10.1017/S1745855207005029 10.1111/j.1360-0443.2008.02159.x 10.1177/0306312704043028 10.1016/j.socscimed.2007.12.006 10.1016/j.pharmthera.2005.06.014 10.1056/NEJMp0801872 10.1016/j.socscimed.2008.02.001 10.1111/j.1360-0443.2006.01774.x 10.1016/j.socscimed.2008.01.010 10.1111/j.1467-9566.2006.00537.x 10.1017/S1745855207005030 10.1111/j.1360-0443.2007.01779.x 10.1001/archpsyc.64.5.566 10.1001/jama.284.13.1689 10.1016/S0895-4356(00)00305-X 10.1007/s11920-007-0046-2 |
ContentType | Journal Article |
Copyright | 2009 Elsevier Ltd 2015 INIST-CNRS Copyright Pergamon Press Inc. Dec 2009 |
Copyright_xml | – notice: 2009 Elsevier Ltd – notice: 2015 INIST-CNRS – notice: Copyright Pergamon Press Inc. Dec 2009 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM DKI X2L 7U3 7U4 8BJ BHHNA DWI FQK JBE K9. WZK 7X8 |
DOI | 10.1016/j.socscimed.2009.09.019 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed RePEc IDEAS RePEc Social Services Abstracts Sociological Abstracts (pre-2017) International Bibliography of the Social Sciences (IBSS) Sociological Abstracts Sociological Abstracts International Bibliography of the Social Sciences International Bibliography of the Social Sciences ProQuest Health & Medical Complete (Alumni) Sociological Abstracts (Ovid) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Sociological Abstracts (pre-2017) ProQuest Health & Medical Complete (Alumni) Social Services Abstracts International Bibliography of the Social Sciences (IBSS) Sociological Abstracts MEDLINE - Academic |
DatabaseTitleList | Sociological Abstracts (pre-2017) Sociological Abstracts (pre-2017) Social Services Abstracts MEDLINE - Academic MEDLINE International Bibliography of the Social Sciences (IBSS) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: DKI name: RePEc IDEAS url: http://ideas.repec.org/ sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health Social Sciences (General) |
EISSN | 1873-5347 |
EndPage | 1790 |
ExternalDocumentID | 1909118691 eeesocmed_v_3a69_3ay_3a2009_3ai_3a12_3ap_3a1784_1790_htm 19819059 22225524 10_1016_j_socscimed_2009_09_019 S0277953609006108 |
Genre | Journal Article Feature |
GeographicLocations | United States North America America United States--US |
GeographicLocations_xml | – name: United States – name: United States--US |
GroupedDBID | --- --K --M -DZ -~X .GJ .~1 07C 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 6PF 7-5 71M 85S 8P~ 9JM 9JO AABNK AACTN AADFP AAEDT AAEDW AAFJI AAGJA AAGJQ AAGUQ AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAWTL AAXUO ABBQC ABFNM ABIVO ABJNI ABLVK ABMAC ABMMH ABMZM ABOCM ABOYX ABPIV ABPPZ ABTAH ABXDB ABYKQ ACDAQ ACGFO ACGFS ACHQT ACRLP ACXNI ADBBV ADEZE AEBSH AEKER AENEX AFDAS AFFNX AFKWA AFTJW AFXIZ AFYLN AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AKYCK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AOMHK ASPBG AVARZ AVWKF AXJTR AZFZN BKOJK BKOMP BLXMC BNPGV CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEH HMK HMO HMY HVGLF HZ~ IH2 IHE J1W K-O KOM L7B LCYCR M29 M3W M3Y M41 MO0 MVM N9A NHB O-L O9- OAUVE OHT OKEIE OZT P-8 P-9 P2P PC. PQQKQ PRBVW Q38 R2- RIG ROL RPZ RXW SAE SCC SDF SDG SDP SES SEW SPCBC SSB SSH SSO SSS SSY SSZ T5K TAE TN5 UHB UQL WH7 WUQ X7L XJT XPP YHZ ZCA ZGI ZY4 ~G- AATTM AAXKI AAYWO AAYXX ACIEU ACVFH ADCNI AEIPS AEUPX AFJKZ AFPUW AGCQF AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION IQODW CGR CUY CVF ECM EFKBS EIF NPM - 08R 0R 1 1AW 8P AAPBV ABFLS ABPTK ACJLH ADALY AVTUQ DKI DZ G- GJ HZ IPNFZ K M OHM PQEST STF TAF X X2L 7U3 7U4 8BJ BHHNA DWI FQK JBE K9. WZK 7X8 |
ID | FETCH-LOGICAL-c590t-2075cda5b24278d7ddf2507fba51e2619064eb02dc369fc9204bb9c2d1b9cb663 |
IEDL.DBID | AIKHN |
ISSN | 0277-9536 1873-5347 |
IngestDate | Fri Jul 11 14:17:34 EDT 2025 Fri Jul 11 09:47:27 EDT 2025 Fri Jul 11 00:50:26 EDT 2025 Fri Jul 11 09:45:42 EDT 2025 Wed Aug 13 10:39:38 EDT 2025 Wed Aug 18 03:10:19 EDT 2021 Mon Jul 21 05:36:42 EDT 2025 Wed Apr 02 07:25:59 EDT 2025 Tue Jul 01 01:59:38 EDT 2025 Thu Apr 24 23:12:38 EDT 2025 Fri Feb 23 02:17:12 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Human subjects USA Substance dependency Clinical trials Bioethics Research ethics Pharmaceutical industry Human Social Inequality Care Ethics Treatment Scientific research Dependence Clinical trial Social medicine Public health |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c590t-2075cda5b24278d7ddf2507fba51e2619064eb02dc369fc9204bb9c2d1b9cb663 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-2 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 19819059 |
PQID | 230489039 |
PQPubID | 46002 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_734162250 proquest_miscellaneous_61351893 proquest_miscellaneous_60336317 proquest_miscellaneous_37252298 proquest_journals_230489039 repec_primary_eeesocmed_v_3a69_3ay_3a2009_3ai_3a12_3ap_3a1784_1790_htm pubmed_primary_19819059 pascalfrancis_primary_22225524 crossref_primary_10_1016_j_socscimed_2009_09_019 crossref_citationtrail_10_1016_j_socscimed_2009_09_019 elsevier_sciencedirect_doi_10_1016_j_socscimed_2009_09_019 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-12-01 |
PublicationDateYYYYMMDD | 2009-12-01 |
PublicationDate_xml | – month: 12 year: 2009 text: 2009-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Kidlington |
PublicationPlace_xml | – name: Kidlington – name: England – name: Oxford |
PublicationSeriesTitle | Social Science & Medicine |
PublicationTitle | Social science & medicine (1982) |
PublicationTitleAlternate | Soc Sci Med |
PublicationYear | 2009 |
Publisher | Elsevier Ltd Elsevier Pergamon Press Inc |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier – name: Pergamon Press Inc |
References | Appelbaum, Roth, Lidz (bib3) 1982; 5 Easter, Henderson, Davis, Churchill, King (bib14) 2006; 28 Worrall (bib51) 2002; 69 Donovan, Wells (bib13) 2007; 102 Braunholtz, Edwards, Lilford (bib7) 2001; 54 Henderson, Churchill, Davis, Easter, Grady, Joffe (bib25) 2007; 4 Himmelstein, Warren, Thorne, Woolhandler (bib26) 2005 Kimmelman (bib29) 2007; 37 Borders, Booth, Han, Wright, Leukefeld, Falck (bib6) 2008; 103 de Melo-Martin, Ho (bib33) 2008; 34 Katz (bib28) 1993; 38 Nicosia, Pacula, Kilmer, Lundberg, Chiesa (bib39) 2009 Miller, Rosentstein (bib35) 2003; 348 Ng (bib38) 2004 Compton, Thomas, Stinson, Grant (bib10) 2007; 64 McLellan, Lewis, O'Brien, Kleber (bib32) 2000; 284 Fatseas, Auriacombe (bib20) 2007; 9 Abraham (bib1) 2007; 2 Berg (bib5) 1997 Winslow, Voorhees, Pehl (bib50) 2007; 76 NDIC (bib37) 2008 Peppercorn, Weeks, Cook, Joffe (bib43) 2004; 363 Roll (bib45) 2007; 102 Pace, Miller, Danis (bib42) 2003; 31 Barr, Panenka, MacEwan, Thornton, Lang, Honer (bib4) 2006; 31 Epstein (bib17) 1996 Lakoff (bib31) 2005 Mumola, Karberg (bib36) 2007 Timmermans, Tavory (bib49) 2007 Miller, Brody (bib34) 2002; 2 Petryna (bib44) 2006; 2 SAMHSA (bib46) 2007 Owen (bib41) 2007 DeNavas-Walt, Proctor, Smith (bib12) 2007 Fisher, Goodman, Skinner, Wennberg (bib21) 2008 Elliott, Abadie (bib16) 2008; 358 Epstein (bib18) 2007 Chambliss (bib9) 1996 Anspach (bib2) 1993 Sismondo (bib48) 2008; 66 Joffe, Cook, Cleary, Clark, Weeks (bib27) 2001; 358 Cunningham, Liu (bib11) 2008; 66 Orr (bib40) 2006 Fisher (bib22) 2008; 66 Fishman (bib23) 2004; 34 Cartwright (bib8) 2007; 2 Grossman, MacKenzie (bib24) 2005; 48 Farmer (bib19) 2005 King (bib30) 2000; 28 Elkashef, Rawson, Smith, Pearce, Flammino, Campbell (bib15) 2007; 102 Saxon, McCarty (bib47) 2005; 108 Anspach (10.1016/j.socscimed.2009.09.019_bib2) 1993 DeNavas-Walt (10.1016/j.socscimed.2009.09.019_bib12) 2007 Orr (10.1016/j.socscimed.2009.09.019_bib40) 2006 Braunholtz (10.1016/j.socscimed.2009.09.019_bib7) 2001; 54 Miller (10.1016/j.socscimed.2009.09.019_bib35) 2003; 348 Appelbaum (10.1016/j.socscimed.2009.09.019_bib3) 1982; 5 Miller (10.1016/j.socscimed.2009.09.019_bib34) 2002; 2 Kimmelman (10.1016/j.socscimed.2009.09.019_bib29) 2007; 37 Easter (10.1016/j.socscimed.2009.09.019_bib14) 2006; 28 Elkashef (10.1016/j.socscimed.2009.09.019_bib15) 2007; 102 Mumola (10.1016/j.socscimed.2009.09.019_bib36) 2007 Farmer (10.1016/j.socscimed.2009.09.019_bib19) 2005 Grossman (10.1016/j.socscimed.2009.09.019_bib24) 2005; 48 Cunningham (10.1016/j.socscimed.2009.09.019_bib11) 2008; 66 Fishman (10.1016/j.socscimed.2009.09.019_bib23) 2004; 34 Cartwright (10.1016/j.socscimed.2009.09.019_bib8) 2007; 2 Joffe (10.1016/j.socscimed.2009.09.019_bib27) 2001; 358 Pace (10.1016/j.socscimed.2009.09.019_bib42) 2003; 31 Timmermans (10.1016/j.socscimed.2009.09.019_bib49) 2007 Elliott (10.1016/j.socscimed.2009.09.019_bib16) 2008; 358 Compton (10.1016/j.socscimed.2009.09.019_bib10) 2007; 64 Chambliss (10.1016/j.socscimed.2009.09.019_bib9) 1996 Peppercorn (10.1016/j.socscimed.2009.09.019_bib43) 2004; 363 de Melo-Martin (10.1016/j.socscimed.2009.09.019_bib33) 2008; 34 Abraham (10.1016/j.socscimed.2009.09.019_bib1) 2007; 2 Worrall (10.1016/j.socscimed.2009.09.019_bib51) 2002; 69 Berg (10.1016/j.socscimed.2009.09.019_bib5) 1997 Epstein (10.1016/j.socscimed.2009.09.019_bib17) 1996 Roll (10.1016/j.socscimed.2009.09.019_bib45) 2007; 102 Owen (10.1016/j.socscimed.2009.09.019_bib41) 2007 Katz (10.1016/j.socscimed.2009.09.019_bib28) 1993; 38 McLellan (10.1016/j.socscimed.2009.09.019_bib32) 2000; 284 Barr (10.1016/j.socscimed.2009.09.019_bib4) 2006; 31 Fisher (10.1016/j.socscimed.2009.09.019_bib21) 2008 Saxon (10.1016/j.socscimed.2009.09.019_bib47) 2005; 108 Henderson (10.1016/j.socscimed.2009.09.019_bib25) 2007; 4 Himmelstein (10.1016/j.socscimed.2009.09.019_bib26) 2005 Epstein (10.1016/j.socscimed.2009.09.019_bib18) 2007 SAMHSA (10.1016/j.socscimed.2009.09.019_bib46) 2007 Ng (10.1016/j.socscimed.2009.09.019_bib38) 2004 Fisher (10.1016/j.socscimed.2009.09.019_bib22) 2008; 66 Lakoff (10.1016/j.socscimed.2009.09.019_bib31) 2005 Borders (10.1016/j.socscimed.2009.09.019_bib6) 2008; 103 NDIC (10.1016/j.socscimed.2009.09.019_bib37) 2008 Winslow (10.1016/j.socscimed.2009.09.019_bib50) 2007; 76 Nicosia (10.1016/j.socscimed.2009.09.019_bib39) 2009 Fatseas (10.1016/j.socscimed.2009.09.019_bib20) 2007; 9 King (10.1016/j.socscimed.2009.09.019_bib30) 2000; 28 Petryna (10.1016/j.socscimed.2009.09.019_bib44) 2006; 2 Donovan (10.1016/j.socscimed.2009.09.019_bib13) 2007; 102 Sismondo (10.1016/j.socscimed.2009.09.019_bib48) 2008; 66 19819602 - Soc Sci Med. 2009 Dec;69(12):1791-2 |
References_xml | – year: 1996 ident: bib17 article-title: Impure science: AIDS, activism, and the politics of knowledge – year: 1996 ident: bib9 article-title: Beyond caring: Hospitals, nurses, and the social organization of ethics – year: 2007 ident: bib12 article-title: Income, poverty, and health insurance coverage in the United States: 2006, Current population reports – volume: 358 start-page: 2316 year: 2008 end-page: 2317 ident: bib16 article-title: Exploiting a research underclass in phase 1 clinical trials publication-title: New England Journal of Medicine – volume: 4 start-page: 1735 year: 2007 end-page: 1738 ident: bib25 article-title: Clinical trials and medical care: defining the therapeutic misconception publication-title: PLOS Medicine – volume: 66 start-page: 1463 year: 2008 end-page: 1473 ident: bib11 article-title: Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment publication-title: Social Science & Medicine – volume: 54 start-page: 217 year: 2001 end-page: 224 ident: bib7 article-title: Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect” publication-title: Journal of Clinical Epidemiology – year: 2005 ident: bib19 article-title: Pathologies of power: Health, human rights, and the new war on the poor – volume: 358 start-page: 1772 year: 2001 end-page: 1777 ident: bib27 article-title: Quality of informed consent in cancer clinical trials: a cross sectional survey publication-title: The Lancet – volume: 64 start-page: 566 year: 2007 end-page: 576 ident: bib10 article-title: Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States publication-title: Archives of General Psychiatry – volume: 28 start-page: 695 year: 2006 end-page: 712 ident: bib14 article-title: The many meanings of care in clinical research publication-title: Sociology of Health and Illness – volume: 2 start-page: 11 year: 2007 end-page: 20 ident: bib8 article-title: Are RCTs the gold standard? publication-title: BioSocieties – volume: 34 start-page: 187 year: 2004 end-page: 218 ident: bib23 article-title: Manufacturing desire: the commodification of female sexual dysfunction publication-title: Social Studies of Science – volume: 38 start-page: 7 year: 1993 end-page: 54 ident: bib28 article-title: Human experimentation and human rights publication-title: Saint Louis University Law Journal – volume: 66 start-page: 2495 year: 2008 end-page: 2505 ident: bib22 article-title: Practicing research ethics: private-sector physicians and pharmaceutical clinical trials publication-title: Social Science & Medicine – year: 2008 ident: bib21 article-title: Tracking the care of patients with severe chronic illness: The Dartmouth atlas of health care 2008 – volume: 66 start-page: 1909 year: 2008 end-page: 1914 ident: bib48 article-title: How pharmaceutical industry funding affects trial outcomes: causal structures and responses publication-title: Social Science & Medicine – volume: 2 start-page: 41 year: 2007 end-page: 56 ident: bib1 article-title: Drug trials and evidence bases in international regulatory context publication-title: BioSocieties – volume: 31 start-page: 301 year: 2006 end-page: 313 ident: bib4 article-title: The need for speed: an update on methamphetamine addiction publication-title: Journal of Psychiatry and Neuroscience – volume: 103 start-page: 800 year: 2008 end-page: 808 ident: bib6 article-title: Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation publication-title: Addiction – year: 2004 ident: bib38 article-title: Drugs: From discovery to approval – volume: 37 start-page: 36 year: 2007 end-page: 42 ident: bib29 article-title: The therapeutic misconception at 25: treatment, research and confusion publication-title: Hastings Center Report – year: 2005 ident: bib31 article-title: Pharmaceutical reason: Knowledge and value in global psychiatry – volume: 9 start-page: 358 year: 2007 end-page: 364 ident: bib20 article-title: Why buprenorphine is so successful in treating opiate addiction in France publication-title: Current Psychiatry Reports – year: 2007 ident: bib36 article-title: Drug use and dependency, state and federal prisoners, 2004 – volume: 284 start-page: 1689 year: 2000 end-page: 1695 ident: bib32 article-title: Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation publication-title: Journal of American Medical Association – year: 2007 ident: bib46 article-title: Results from the 2006 national survey on drug use and health: National findings – volume: 28 start-page: 332 year: 2000 end-page: 343 ident: bib30 article-title: Defining and describing benefit appropriately in clinical trials publication-title: Journal of Law, Medicine, and Ethics – volume: 102 start-page: 114 year: 2007 end-page: 140 ident: bib45 article-title: Contingency management: an evidence-based component of methamphetamine use disorder treatments publication-title: Addiction – year: 2009 ident: bib39 article-title: The economic cost of methamphetamine use in the United States, 2005 – year: 2007 ident: bib41 article-title: The speed limit: The highs and lows of meth – volume: 108 start-page: 119 year: 2005 end-page: 128 ident: bib47 article-title: Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs publication-title: Pharmacology and Therapeutics – volume: 2 start-page: 21 year: 2006 end-page: 40 ident: bib44 article-title: Clinical trials offshored: on private sector science and public health publication-title: BioSocieties – volume: 5 start-page: 319 year: 1982 end-page: 329 ident: bib3 article-title: The therapeutic misconception: informed consent in psychiatric research publication-title: International Journal of Law and Psychiatry – volume: 2 start-page: 3 year: 2002 end-page: 9 ident: bib34 article-title: What makes placebo-controlled trials unethical? publication-title: American Journal of Bioethics – start-page: 493 year: 2007 end-page: 513 ident: bib49 article-title: Advancing ethnographic research through grounded theory practice publication-title: Handbook of grounded theory – volume: 102 start-page: 107 year: 2007 end-page: 113 ident: bib15 article-title: The NIDA methamphetamine clinical trials group: a strategy to increase clinical trials research capacity publication-title: Addiction – volume: 348 start-page: 1383 year: 2003 end-page: 1386 ident: bib35 article-title: The therapeutic orientation to clinical trials publication-title: New England Journal of Medicine – year: 2007 ident: bib18 article-title: Inclusion: The politics of difference in medical research – year: 2008 ident: bib37 article-title: National drug threat assessment – year: 1997 ident: bib5 article-title: Rationalizing medical work: Decision support techniques and medical practices – year: 1993 ident: bib2 article-title: Deciding who lives: Fateful choices in the intensive care nursery – start-page: 65 year: 2005 end-page: 73 ident: bib26 article-title: Illness and injury as contributors to bankruptcy publication-title: Health Affairs(W5) – volume: 102 start-page: 121 year: 2007 end-page: 129 ident: bib13 article-title: ‘Tweaking 12-step’: the potential role of 12-step self-help group involvement in methamphetamine recovery publication-title: Addiction – volume: 31 start-page: S121 year: 2003 end-page: S125 ident: bib42 article-title: Enrolling the uninsured in clinical trials: an ethical perspective publication-title: Critical Care Medicine – year: 2006 ident: bib40 article-title: Panic diaries: A genealogy of panic disorder – volume: 76 start-page: 1169 year: 2007 end-page: 1174 ident: bib50 article-title: Methamphetamine abuse publication-title: American Family Physician – volume: 34 start-page: 202 year: 2008 end-page: 205 ident: bib33 article-title: Beyond informed consent: the therapeutic misconception and trust publication-title: British Medical Journal – volume: 363 start-page: 263 year: 2004 end-page: 270 ident: bib43 article-title: Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review publication-title: Lancet – volume: 69 start-page: S316 year: 2002 end-page: S330 ident: bib51 article-title: What evidence in evidence-based medicine publication-title: Philosophy of Science – volume: 48 start-page: 516 year: 2005 end-page: 534 ident: bib24 article-title: The randomized controlled trial: gold standard or merely standard publication-title: Perspectives in Biology and Medicine – volume: 48 start-page: 516 issue: 4 year: 2005 ident: 10.1016/j.socscimed.2009.09.019_bib24 article-title: The randomized controlled trial: gold standard or merely standard publication-title: Perspectives in Biology and Medicine doi: 10.1353/pbm.2005.0092 – volume: 28 start-page: 332 year: 2000 ident: 10.1016/j.socscimed.2009.09.019_bib30 article-title: Defining and describing benefit appropriately in clinical trials publication-title: Journal of Law, Medicine, and Ethics doi: 10.1111/j.1748-720X.2000.tb00685.x – volume: 31 start-page: S121 issue: 3 year: 2003 ident: 10.1016/j.socscimed.2009.09.019_bib42 article-title: Enrolling the uninsured in clinical trials: an ethical perspective publication-title: Critical Care Medicine doi: 10.1097/01.CCM.0000054907.33928.48 – volume: 348 start-page: 1383 issue: 14 year: 2003 ident: 10.1016/j.socscimed.2009.09.019_bib35 article-title: The therapeutic orientation to clinical trials publication-title: New England Journal of Medicine doi: 10.1056/NEJMsb030228 – year: 2005 ident: 10.1016/j.socscimed.2009.09.019_bib31 – volume: 69 start-page: S316 year: 2002 ident: 10.1016/j.socscimed.2009.09.019_bib51 article-title: What evidence in evidence-based medicine publication-title: Philosophy of Science doi: 10.1086/341855 – volume: 2 start-page: 41 issue: 1 year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib1 article-title: Drug trials and evidence bases in international regulatory context publication-title: BioSocieties doi: 10.1017/S1745855207005042 – volume: 38 start-page: 7 issue: 1 year: 1993 ident: 10.1016/j.socscimed.2009.09.019_bib28 article-title: Human experimentation and human rights publication-title: Saint Louis University Law Journal – volume: 5 start-page: 319 issue: 3–4 year: 1982 ident: 10.1016/j.socscimed.2009.09.019_bib3 article-title: The therapeutic misconception: informed consent in psychiatric research publication-title: International Journal of Law and Psychiatry doi: 10.1016/0160-2527(82)90026-7 – volume: 102 start-page: 121 issue: Suppl. 1 year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib13 article-title: ‘Tweaking 12-step’: the potential role of 12-step self-help group involvement in methamphetamine recovery publication-title: Addiction doi: 10.1111/j.1360-0443.2007.01773.x – year: 1997 ident: 10.1016/j.socscimed.2009.09.019_bib5 – year: 1996 ident: 10.1016/j.socscimed.2009.09.019_bib17 – volume: 358 start-page: 1772 issue: 9295 year: 2001 ident: 10.1016/j.socscimed.2009.09.019_bib27 article-title: Quality of informed consent in cancer clinical trials: a cross sectional survey publication-title: The Lancet doi: 10.1016/S0140-6736(01)06805-2 – year: 2004 ident: 10.1016/j.socscimed.2009.09.019_bib38 – volume: 34 start-page: 202 issue: 3 year: 2008 ident: 10.1016/j.socscimed.2009.09.019_bib33 article-title: Beyond informed consent: the therapeutic misconception and trust publication-title: British Medical Journal – year: 2005 ident: 10.1016/j.socscimed.2009.09.019_bib19 – volume: 4 start-page: 1735 issue: 11 year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib25 article-title: Clinical trials and medical care: defining the therapeutic misconception publication-title: PLOS Medicine doi: 10.1371/journal.pmed.0040324 – volume: 37 start-page: 36 issue: 6 year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib29 article-title: The therapeutic misconception at 25: treatment, research and confusion publication-title: Hastings Center Report doi: 10.1353/hcr.2007.0092 – volume: 2 start-page: 3 issue: 2 year: 2002 ident: 10.1016/j.socscimed.2009.09.019_bib34 article-title: What makes placebo-controlled trials unethical? publication-title: American Journal of Bioethics doi: 10.1162/152651602317533523 – volume: 363 start-page: 263 issue: 9405 year: 2004 ident: 10.1016/j.socscimed.2009.09.019_bib43 article-title: Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review publication-title: Lancet doi: 10.1016/S0140-6736(03)15383-4 – year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib36 – year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib41 – volume: 2 start-page: 11 issue: 1 year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib8 article-title: Are RCTs the gold standard? publication-title: BioSocieties doi: 10.1017/S1745855207005029 – volume: 103 start-page: 800 year: 2008 ident: 10.1016/j.socscimed.2009.09.019_bib6 article-title: Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation publication-title: Addiction doi: 10.1111/j.1360-0443.2008.02159.x – volume: 34 start-page: 187 issue: 2 year: 2004 ident: 10.1016/j.socscimed.2009.09.019_bib23 article-title: Manufacturing desire: the commodification of female sexual dysfunction publication-title: Social Studies of Science doi: 10.1177/0306312704043028 – volume: 66 start-page: 1463 year: 2008 ident: 10.1016/j.socscimed.2009.09.019_bib11 article-title: Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment publication-title: Social Science & Medicine doi: 10.1016/j.socscimed.2007.12.006 – start-page: 65 year: 2005 ident: 10.1016/j.socscimed.2009.09.019_bib26 article-title: Illness and injury as contributors to bankruptcy publication-title: Health Affairs(W5) – volume: 108 start-page: 119 year: 2005 ident: 10.1016/j.socscimed.2009.09.019_bib47 article-title: Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs publication-title: Pharmacology and Therapeutics doi: 10.1016/j.pharmthera.2005.06.014 – volume: 358 start-page: 2316 issue: 22 year: 2008 ident: 10.1016/j.socscimed.2009.09.019_bib16 article-title: Exploiting a research underclass in phase 1 clinical trials publication-title: New England Journal of Medicine doi: 10.1056/NEJMp0801872 – volume: 76 start-page: 1169 issue: 8 year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib50 article-title: Methamphetamine abuse publication-title: American Family Physician – year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib46 – volume: 66 start-page: 2495 issue: 12 year: 2008 ident: 10.1016/j.socscimed.2009.09.019_bib22 article-title: Practicing research ethics: private-sector physicians and pharmaceutical clinical trials publication-title: Social Science & Medicine doi: 10.1016/j.socscimed.2008.02.001 – volume: 102 start-page: 114 issue: Suppl. 1 year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib45 article-title: Contingency management: an evidence-based component of methamphetamine use disorder treatments publication-title: Addiction doi: 10.1111/j.1360-0443.2006.01774.x – volume: 66 start-page: 1909 year: 2008 ident: 10.1016/j.socscimed.2009.09.019_bib48 article-title: How pharmaceutical industry funding affects trial outcomes: causal structures and responses publication-title: Social Science & Medicine doi: 10.1016/j.socscimed.2008.01.010 – year: 2008 ident: 10.1016/j.socscimed.2009.09.019_bib21 – volume: 28 start-page: 695 issue: 6 year: 2006 ident: 10.1016/j.socscimed.2009.09.019_bib14 article-title: The many meanings of care in clinical research publication-title: Sociology of Health and Illness doi: 10.1111/j.1467-9566.2006.00537.x – volume: 2 start-page: 21 issue: 1 year: 2006 ident: 10.1016/j.socscimed.2009.09.019_bib44 article-title: Clinical trials offshored: on private sector science and public health publication-title: BioSocieties doi: 10.1017/S1745855207005030 – volume: 102 start-page: 107 issue: Suppl. 1 year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib15 article-title: The NIDA methamphetamine clinical trials group: a strategy to increase clinical trials research capacity publication-title: Addiction doi: 10.1111/j.1360-0443.2007.01779.x – volume: 64 start-page: 566 issue: May year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib10 article-title: Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States publication-title: Archives of General Psychiatry doi: 10.1001/archpsyc.64.5.566 – volume: 284 start-page: 1689 issue: 13 year: 2000 ident: 10.1016/j.socscimed.2009.09.019_bib32 article-title: Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation publication-title: Journal of American Medical Association doi: 10.1001/jama.284.13.1689 – volume: 31 start-page: 301 issue: 5 year: 2006 ident: 10.1016/j.socscimed.2009.09.019_bib4 article-title: The need for speed: an update on methamphetamine addiction publication-title: Journal of Psychiatry and Neuroscience – year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib18 – year: 1996 ident: 10.1016/j.socscimed.2009.09.019_bib9 – year: 2006 ident: 10.1016/j.socscimed.2009.09.019_bib40 – year: 1993 ident: 10.1016/j.socscimed.2009.09.019_bib2 – volume: 54 start-page: 217 year: 2001 ident: 10.1016/j.socscimed.2009.09.019_bib7 article-title: Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect” publication-title: Journal of Clinical Epidemiology doi: 10.1016/S0895-4356(00)00305-X – volume: 9 start-page: 358 issue: 5 year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib20 article-title: Why buprenorphine is so successful in treating opiate addiction in France publication-title: Current Psychiatry Reports doi: 10.1007/s11920-007-0046-2 – year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib12 – start-page: 493 year: 2007 ident: 10.1016/j.socscimed.2009.09.019_bib49 article-title: Advancing ethnographic research through grounded theory practice – year: 2008 ident: 10.1016/j.socscimed.2009.09.019_bib37 – year: 2009 ident: 10.1016/j.socscimed.2009.09.019_bib39 – reference: 19819602 - Soc Sci Med. 2009 Dec;69(12):1791-2 |
SSID | ssj0001083 |
Score | 2.2115617 |
Snippet | Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual... |
SourceID | proquest repec pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1784 |
SubjectTerms | Addiction Bioethical Issues Bioethics Biological and medical sciences Clinical trials Clinical Trials, Phase III as Topic - ethics Conflict of Interest Drug abuse Drugs Ethics Health care Health Services Accessibility - ethics Healthcare Disparities Human subjects Humans Interviews as Topic Medical research Medical sciences Medications Methamphetamine Miscellaneous Pharmaceutical industry Primary care Public health. Hygiene Public health. Hygiene-occupational medicine Randomized Controlled Trials as Topic - ethics Research Design Research Ethics Research Subjects - psychology Researcher-Subject Relations Social research Substance Abuse Substance dependency Substance-Related Disorders - therapy Teaching. Deontology. Ethics. Legislation U.S.A United States United States of America USA USA Clinical trials Pharmaceutical industry Human subjects Research ethics Substance dependency Bioethics |
Title | Clinical trials as treatment option: Bioethics and health care disparities in substance dependency |
URI | https://dx.doi.org/10.1016/j.socscimed.2009.09.019 https://www.ncbi.nlm.nih.gov/pubmed/19819059 http://econpapers.repec.org/article/eeesocmed/v_3a69_3ay_3a2009_3ai_3a12_3ap_3a1784-1790.htm https://www.proquest.com/docview/230489039 https://www.proquest.com/docview/37252298 https://www.proquest.com/docview/60336317 https://www.proquest.com/docview/61351893 https://www.proquest.com/docview/734162250 |
Volume | 69 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwELYoSFUlVMH2FWi3PvTQHtJNnMSJuQHtaimCS4vEzYofEaloNiIBiUt_e2cSJ4AE5YCUWLtrezc7Hs98ybwI-RTnBdcBZ77ghvmxypSfRVr5msUwBYsdFxiNfHTMFyfxj9PkdIXsD7Ew6FbpZH8v0ztp7T6ZOWrO6rKc_UTrIxofA4F6GAN-11gkOLD22u7B4eJ4FMjQ1xmab6yVt9y8gAbw7aB5XO5KODDrzv1Kar3OGyBd0de8uA-UAsa9sLXVt5TUfIO8dOiS7vZ_YJOs2GpCnh85-_mErPdP6WgffDQhXh-dS90Ob-hnl4b6yyuiXMrQc9pV9mho3tDRLZ0uO1GzQ_fKpe1c5mleGdpHVVJ0J6OmbLDCISZspWVFG5BQLbIYHeru6uvX5GT-_df-wncVGXydiKCFLZUm2uSJYlihw6TGFACh0kLlSWjxXgwAjlUBMzriotCCBbFSQjMTQqsA3Lwhq9Wysu8IzRQXiVCAQEwY6zhTCqCY6kKJM0wL5hE-LIHULl05Vs04l4Nf2m85rh0W0xQSj1B4JBgn1n3Gjsen7AxrLO8wnwS98vjk6R2uGH-U4a10wmKPbA9sIp2AaCQ-i89EEMH0j2Mv7Gw01-SVXV42MkoZgGORPTyCB1HEAQD-ZwQWYARI6hH6wIgUYAyHCwWCv-1Z-IZqAuFiApc473h67LDWAilw6JWMci6guYazI0qUl3CGDJoaX6RZLDELnDxr_2w9hc7b5AVztTuC8D1ZbS8u7QcAhK2akmdf_4ZTt-3h3bfDg3-EMGC7 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqIgFShWB5NBRaHzjAIWziOE7cG1SsFuj2Qiv1ZsWPiKCSjZptpV747cwkTraVWnpASqzV2t61xjPjL5kXIe94UQoTCRZKYVnIda7DPDE6NIzDFCx2XGI08uJIzE_4t9P0dIMcDLEw6FbpdX-v0ztt7b-ZempOm6qa_kDrIxofI4nnMAb8PuAgviidH_-s_TygpzMzr22V15y8gALw23Du-MyVcGHOnduPqK2maIFwZV_x4jZICgj33DXOXDuiZk_JE48t6ad--c_Ihqsn5OHCW88nZKt_R0f70KMJCfrYXOrlu6XvfRLqD8-J9glDz2hX16OlRUtHp3S67BTNPv1cLV3nME-L2tI-ppKiMxm1VYv1DTFdK61q2oJ-WiGD0aHqrrl6QU5mX44P5qGvxxCaVEYrEKgsNbZINcP6HDaztgQAlZW6SGOHT2IAb5yOmDWJkKWRLOJaS8NsDK0GaPOSbNbL2m0TmmshU6kBf9iYG55rDUBMd4HEOSYFC4gYtkAZn6wca2acqcEr7Zca9w5LaUqFVywDEo0Tmz5fx_1T9oc9VjdYT8Gpcv_k3RtcMf4pwwfplPGA7Axsorx6aBW-ic9llMD0vbEX5BqNNUXtlhetSjIG0Fjmd48QUZIIgH__GIHlFwGQBoTeMSIDECNgoUDwVz0Lr6kmESymsMRZx9Njh3MOSIFDL1VSCAnNFdwdUZKigjtm0DT4Icu5whxw6ufq9-v_ofMeeTQ_Xhyqw69H33fIY-areETxG7K5Or9wbwEarvRuJ_p_AS5zYIY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+trials+as+treatment+option%3A+Bioethics+and+health+care+disparities+in+substance+dependency&rft.jtitle=Social+science+%26+medicine+%281982%29&rft.au=Timmermans%2C+Stefan&rft.au=McKay%2C+Tara&rft.series=Social+Science+%26+Medicine&rft.date=2009-12-01&rft.pub=Elsevier&rft.issn=0277-9536&rft.eissn=1873-5347&rft.volume=69&rft.issue=12&rft.spage=1784&rft.epage=1790&rft_id=info:doi/10.1016%2Fj.socscimed.2009.09.019&rft.externalDocID=eeesocmed_v_3a69_3ay_3a2009_3ai_3a12_3ap_3a1784_1790_htm |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-9536&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-9536&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-9536&client=summon |